Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Subject Collections
    • JASN Podcasts
    • Archives
    • Saved Searches
    • ASN Meeting Abstracts
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Subscriptions
  • More
    • About JASN
    • Alerts
    • Advertising
    • Editorial Fellowship Program
    • Feedback
    • Reprints
    • Impact Factor
  • ASN Kidney News
  • Other
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Subject Collections
    • JASN Podcasts
    • Archives
    • Saved Searches
    • ASN Meeting Abstracts
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Subscriptions
  • More
    • About JASN
    • Alerts
    • Advertising
    • Editorial Fellowship Program
    • Feedback
    • Reprints
    • Impact Factor
  • ASN Kidney News
  • Follow JASN on Twitter
  • Visit ASN on Facebook
  • Follow JASN on RSS
  • Community Forum
Clinical Epidemiology
You have accessRestricted Access

Long-Term Outcomes in Idiopathic Membranous Nephropathy Using a Restrictive Treatment Strategy

Jan A.J.G. van den Brand, Peter R. van Dijk, Julia M. Hofstra and Jack F.M. Wetzels
JASN January 2014, 25 (1) 150-158; DOI: https://doi.org/10.1681/ASN.2013020185
Jan A.J.G. van den Brand
*Department of Nephrology, Radboud University Medical Centre, Nijmegen, The Netherlands, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter R. van Dijk
†Department of Internal Medicine, Isala Clinics, Zwolle, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julia M. Hofstra
*Department of Nephrology, Radboud University Medical Centre, Nijmegen, The Netherlands, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jack F.M. Wetzels
*Department of Nephrology, Radboud University Medical Centre, Nijmegen, The Netherlands, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data Supps
  • Info & Metrics
  • View PDF
Loading

Article Information

vol. 25 no. 1 150-158
DOI 
https://doi.org/10.1681/ASN.2013020185
PubMed 
24029426

Published By 
American Society of Nephrology
Print ISSN 
1046-6673
Online ISSN 
1533-3450
History 
  • Received for publication February 28, 2013
  • Accepted for publication June 28, 2013
  • Published online December 31, 2013.

Article Versions

  • Earlier version (September 12, 2013 - 11:44).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2014 by the American Society of Nephrology

Author Information

  1. Jan A.J.G. van den Brand*,
  2. Peter R. van Dijk†,
  3. Julia M. Hofstra* and
  4. Jack F.M. Wetzels*
  1. *Department of Nephrology, Radboud University Medical Centre, Nijmegen, The Netherlands, and
  2. †Department of Internal Medicine, Isala Clinics, Zwolle, The Netherlands
  1. Correspondence:
    Jan A.J.G. van den Brand, Department of Nephrology, Radboud University Medical Centre, 464, PO Box 9101, 6500 HB Nijmegen, The Netherlands. Email: a.vandenbrand{at}nier.umcn.nl
View Abstract

Statistics from Altmetric.com

Article usage

Article usage: September 2013 to December 2020

AbstractFullPdf
Sep 2013584368223
Oct 20132774786
Nov 20131562533
Dec 20132262734
Jan 20142575111334
Feb 201478134114
Mar 20145853796
Apr 20143542851
May 20142262332
Jun 20142032237
Jul 20141501731
Aug 2014911925
Sep 20141291829
Oct 20141141833
Nov 20141311422
Dec 2014941719
Jan 2015974543
Feb 2015793126
Mar 2015954752
Apr 2015563935
May 2015723849
Jun 2015633666
Jul 2015513938
Aug 2015532420
Sep 2015382620
Oct 2015592231
Nov 2015542627
Dec 2015373431
Jan 2016332418
Feb 2016482822
Mar 2016391522
Apr 2016603534
May 2016602729
Jun 2016452827
Jul 2016534041
Aug 2016362421
Sep 2016421727
Oct 2016582022
Nov 2016381935
Dec 2016402328
Jan 2017453132
Feb 2017612920
Mar 2017342219
Apr 2017462322
May 2017292717
Jun 2017251417
Jul 2017291714
Aug 2017371614
Sep 2017502530
Oct 2017412833
Nov 2017352325
Dec 2017252016
Jan 2018332420
Feb 2018262319
Mar 2018302626
Apr 2018282410
May 2018253420
Jun 201892821
Jul 2018302522
Aug 2018143520
Sep 201853723
Oct 20186348
Nov 201874822
Dec 201832718
Jan 201953823
Feb 201954113
Mar 201943922
Apr 201945214
May 201914214
Jun 201933720
Jul 201925727
Aug 201967914
Sep 20191511021
Oct 2019124216
Nov 201976416
Dec 201944415
Jan 202033511
Feb 202084620
Mar 202042817
Apr 202012710
May 202055120
Jun 202013213
Jul 20205286
Aug 202022513
Sep 202053913
Oct 2020103817
Nov 2020125822
Dec 202073520

Cited By...

  • 44 Citations
  • Google Scholar
PreviousNext
Back to top

In this issue

Journal of the American Society of Nephrology: 25 (1)
Journal of the American Society of Nephrology
Vol. 25, Issue 1
January 2014
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
View Selected Citations (0)
Print
Download PDF
Sign up for Alerts
Email Article
Thank you for your help in sharing the high-quality science in JASN.
Enter multiple addresses on separate lines or separate them with commas.
Long-Term Outcomes in Idiopathic Membranous Nephropathy Using a Restrictive Treatment Strategy
(Your Name) has sent you a message from American Society of Nephrology
(Your Name) thought you would like to see the American Society of Nephrology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Long-Term Outcomes in Idiopathic Membranous Nephropathy Using a Restrictive Treatment Strategy
Jan A.J.G. van den Brand, Peter R. van Dijk, Julia M. Hofstra, Jack F.M. Wetzels
JASN Jan 2014, 25 (1) 150-158; DOI: 10.1681/ASN.2013020185

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Long-Term Outcomes in Idiopathic Membranous Nephropathy Using a Restrictive Treatment Strategy
Jan A.J.G. van den Brand, Peter R. van Dijk, Julia M. Hofstra, Jack F.M. Wetzels
JASN Jan 2014, 25 (1) 150-158; DOI: 10.1681/ASN.2013020185
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Results
    • Discussion
    • Concise Methods
    • Disclosures
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data Supps
  • Info & Metrics
  • View PDF

More in this TOC Section

  • Subtyping CKD Patients by Consensus Clustering: The Chronic Renal Insufficiency Cohort (CRIC) Study
  • Long-Term Exposure to Ambient PM2.5 and Increased Risk of CKD Prevalence in China
  • Association of Multiple Plasma Biomarker Concentrations with Progression of Prevalent Diabetic Kidney Disease: Findings from the Chronic Renal Insufficiency Cohort (CRIC) Study
Show more Clinical Epidemiology

Cited By...

  • Safety of Rituximab Compared with Steroids and Cyclophosphamide for Idiopathic Membranous Nephropathy
  • Primary Membranous Nephropathy
  • Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up
  • Association of Anti-PLA2R Antibodies with Outcomes after Immunosuppressive Therapy in Idiopathic Membranous Nephropathy
  • Cancer Risk after Cyclophosphamide Treatment in Idiopathic Membranous Nephropathy
  • Google Scholar

Similar Articles

Related Articles

  • PubMed
  • Google Scholar

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Annual Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Author Resources
  • Editorial Fellowship Program
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • JASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About JASN
  • JASN Email Alerts
  • JASN Key Impact Information
  • JASN Podcasts
  • JASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Password/Email Address Changes
  • Subscribe

© 2021 American Society of Nephrology

Print ISSN - 1046-6673 Online ISSN - 1533-3450

Powered by HighWire